Ethereum, Ripple, Cardano, Solana, and Injective Price Analysis

Reportedly, this week we are focusing on the price trends of Ethereum, Ripple, Cardano, Solana, and Injective. Ethereum (ETH) once again lags behind Bitcoin, and the entire market fails to truly take off. The price returned to the support level of $2,150, with a 2% decrease in market capitalization this week. Despite Ethereum possibly being among the last batch of altcoins to rise, the price trend is worrisome, indicating a complete lack of bullish momentum. Additionally, if any upward movement occurs, there is strong resistance between $2,400 and $2,500. Looking ahead, if a bear market returns, ETH has good support around $2,000 after breaking below $2,150.

Ripple (XRP) continues to maintain a steady trend, with a 1.5% decrease in price this week. The resistance at $0.68 and support at $0.54 remain unchanged. However, the more significant news is that XRP is losing to Solana in total market capitalization, with the latter experiencing double-digit growth this week. Looking forward, XRP needs to recover its upward trend, or it may lose to competitors that have recently gained more attention.

Cardano (ADA) failed to rise this week, closing with a 10% decrease. Previously, the price lost support at $0.60, and now this level has become resistance. With the pause in the upward movement, Cardano is at a critical moment. If it fails to return above $0.60, sellers may take over, pushing it into a deeper correction. Looking ahead, if a bear market returns, this cryptocurrency has strong support at $0.46. As long as the crucial resistance holds, sellers have the upper hand.

Solana (SOL) had an impressive action this week, breaking through $78, with a 20% price increase. At the same time, it replaced XRP as the fifth-largest cryptocurrency. If this upward trend continues, Solana is less than 25% away from a three-digit valuation. Considering the current market momentum, this could happen soon. Looking ahead, SOL's bias remains bullish, and sellers seem to have left or are too weak to regain control of the price.

Injective (INJ) performed better than most of the market, with a 28% price increase this week. Since mid-December, INJ has been on an upward trajectory. During this process, the price reached $43, setting a new record and all-time high. However, this uptrend has pushed the price to the limit of this upward channel, which may now act as resistance. Looking ahead, INJ may experience a brief pullback here and then resume the upward trend. If this happens, there is strong support at $31.